在日常实践中实施临床药物审查的经验和挑战:一种混合方法研究
Sek Hung Chau1,2, Petra J M Elders3,4, Jacintha Domić5
1Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. s.chau@amsterdamumc.nl.
International journal of clinical pharmacy
|September 9, 2025
概括
使用患者问卷和药物审查专家团队的Opti-Med2方法显示出有前途. 虽然没有实现全面实施,但它的结构化方法和患者参与是成功的.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健管理的管理
- 实施科学 实施科学
背景情况:
- 组织挑战阻碍了广泛的临床药物审查 (CMRs).
- 该Opti-Med2方法是为了简化CMR而开发的,它结合了患者问卷和专家团队 (社区药剂师,全科医生).
- 社区的药房技术人员和一般医务人员支持这个过程.
研究的目的:
- 评估荷兰药物治疗审计会议小组内Opti-Med2方法的实施情况.
- 评估Opti-Med2方法在初级保健机构的可行性和接受性.
主要方法:
- 一项涉及七个初级保健提供者团体的混合方法实施研究.
- 通过研究表格收集的定量数据.
- 从与全科医生 (GPs),社区药剂师和技术人员的半结构面试中获得的定性数据,使用规范化过程理论进行分析.
主要成果:
- 只有一个组提供了足够的定量数据进行分析.
- 72%的专家团队药物治疗建议被全科医生采用,导致85%的采用病例进行患者干预.
- 医疗保健提供者对Opti-Med2方法表示满意,特别赞赏专家团队和患者问卷.
结论:
- 没有完全实现Opti-Med2方法的全面实施.
- 进行CMR的结构化组织和使用患者问卷被认为是成功的.
- 该研究强调了结构化方法和患者参与改善药物审查的潜力.
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Measurement of Bioavailability: Pharmacodynamic Methods
206
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
206
Therapeutic Drug Monitoring: Affecting Factors
163
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
163
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
375
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Methods of Documentation VI: Case Management Model
829
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
829
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K


